OnabotulinumtoxinA for Overactive Bladder and Urinary Incontinence

被引：1
|
作者：
Chancellor, Michael B. [1 ]
机构：
[1] Beaumont Hlth & Oakland Univ, Aikens Res Ctr, William Beaumont Sch Med, Dept Urol, Rochester, MN 48309 USA
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 02期
关键词：
EFFICACY; SAFETY;
D O I：
10.1016/j.juro.2016.11.077
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：S224 / S236
页数：13
相关论文
共 50 条
  • [41] REDUCTION IN URINARY INCONTINENCE AND IMPROVEMENT IN QUALITY OF LIFE WITH ONABOTULINUMTOXINA IN OVERACTIVE BLADDER PATIENTS IS UNAFFECTED BY THE USE OF CLEAN INTERMITTENT CATHETERIZATION OR THE PRESENCE OF URINARY TRACT INFECTION
    Sussman, David
    Gruenenfelder, Jennifer
    Schulte-Baukloh, Heinrich
    Guard, Steven
    Zheng, Yan
    Everaert, Karel
    JOURNAL OF UROLOGY, 2014, 191 (04): : E883 - E884
  • [42] Effect of Transobturator Tape on Overactive Bladder Symptoms and Urge Urinary Incontinence in Women With Mixed Urinary Incontinence
    Tahseen, Samina
    Reid, Peter
    OBSTETRICS AND GYNECOLOGY, 2009, 113 (03): : 617 - 623
  • [43] Comparisons of urodynamic characteristics between female patients with overactive bladder and overactive bladder plus stress urinary incontinence
    Lin, LY
    Yeh, NH
    Lin, CY
    Sheu, BC
    Lin, HH
    UROLOGY, 2004, 64 (05) : 945 - 949
  • [44] REDUCTIONIN INCONTINENCE PRODUCTUSE ANDASSOCIATED COST SAVINGS AFTER ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH OVERACTIVE BLADDER
    Farrelly, Elisabeth
    Lorenzo-Gomez, Maria-Fernanda
    Hamid, Rizwan
    Boroujerdi, Amin
    Schulte-Baukloh, Heinrich
    JOURNAL OF UROLOGY, 2021, 206 : E309 - E309
  • [45] REAL-WORLD IMPROVEMENT IN URINARY SYMPTOMS AND INCIDENCE OF URINARY RETENTION WITH ONABOTULINUMTOXINA IN PATIENTS WITH OVERACTIVE BLADDER
    Hamid, Rizwan
    Lorenzo-Gomez, Maria-Fernanda
    Schulte-Baukloh, Heinrich
    Boroujerdi, Amin
    Patel, Anand
    Farrelly, Elisabeth
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1189 - E1189
  • [46] The Correlation of Diabetes Mellitus and Urinary Retention From Intravesical OnabotulinumtoxinA Injection for Overactive Bladder
    Takashima, Yoko
    Handler, Stephanie
    Laus, Katharina
    Eckhardt, Sarah
    Whitaker, Taylor
    Tenggardjaja, Christopher
    Yazdany, Tajnoos
    UROGYNECOLOGY, 2023, 29 (05): : 511 - 519
  • [47] ONABOTULINUMTOXINA DEMONSTRATES SIMILAR IMPROVEMENTS IN URINARY INCONTINENCE AND QUALITY OF LIFE REGARDLESS OF THE USE OF CLEAN INTERMITTENT CATHETERISATION OR THE PRESENCE OF URINARY TRACT INFECTION IN PATIENTS WITH OVERACTIVE BLADDER
    Everaert, K.
    Gruenenfelder, J.
    Schulte-Baukloh, H.
    Guard, S.
    Zheng, Y.
    Sussman, D.
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (06) : 768 - 769
  • [48] Postpartum depression, urge urinary incontinence, and overactive bladder syndrome: is there an association?
    Hullfish, Kathie L.
    Fenner, Dee E.
    Sorser, Serge A.
    Visger, Jennifer
    Clayton, Anita
    Steers, William D.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2007, 18 (10) : 1121 - 1126
  • [49] Overactive bladder, stress urinary incontinence, and menopause-what are the associations?
    Clark, Amanda L.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2022, 29 (02): : 125 - 126
  • [50] Costs of urinary incontinence and overactive bladder in the United States: A comparative study
    Hu, TW
    Wagner, TH
    Bentkover, JD
    LeBlanc, K
    Zhou, SZ
    Hunt, T
    UROLOGY, 2004, 63 (03) : 461 - 465
12345